Market Overview

Usana Health Sciences: Q2 Earnings Insights


Shares of Usana Health Sciences (NYSE:USNA) fell 4.17% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share rose 45.05% year over year to $1.32, which beat the estimate of $1.10.

Revenue of $258,991,000 higher by 1.16% from the same period last year, which missed the estimate of $264,150,000.


Usana Health Sciences hasn't issued any earnings guidance for the time being.

Usana Health Sciences hasn't issued any revenue guidance for the time being.

Recent Stock Performance

Company's 52-week high was at $91.26

Company's 52-week low was at $43.01

Price action over last quarter: Up 12.79%

Company Overview

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe, with the majority of its revenue generated from markets outside the United States.


Related Articles (USNA)

View Comments and Join the Discussion!

Posted-In: Earnings